Øyvind Molberg Selected Research

Mixed Connective Tissue Disease (MCTD)

12/2017	Disease evolution in mixed connective tissue disease: results from a long-term nationwide prospective cohort study.
1/2016	Associations between anti-Ro52 antibodies and lung fibrosis in mixed connective tissue disease.
1/2016	Mixed connective tissue disease.
8/2015	Associations between circulating endostatin levels and vascular organ damage in systemic sclerosis and mixed connective tissue disease: an observational study.
3/2015	The HLA profiles of mixed connective tissue disease differ distinctly from the profiles of clinically related connective tissue diseases.
7/2013	Prevalence of pulmonary hypertension in an unselected, mixed connective tissue disease cohort: results of a nationwide, Norwegian cross-sectional multicentre study and review of current literature.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Øyvind Molberg Research Topics

Disease

13	Systemic Scleroderma (Systemic Sclerosis) 01/2022 - 08/2015
10	Celiac Disease (Celiac Sprue) 10/2021 - 09/2002
9	Myositis (Idiopathic Inflammatory Myopathies) 01/2022 - 08/2009
9	Fibrosis (Cirrhosis) 01/2021 - 10/2005
6	Inflammation (Inflammations) 01/2022 - 08/2003
6	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2019 - 08/2009
6	Mixed Connective Tissue Disease (MCTD) 12/2017 - 07/2013
5	Pulmonary Hypertension 10/2020 - 01/2016
4	Pulmonary Arterial Hypertension 10/2020 - 08/2015
4	Rheumatoid Arthritis 01/2018 - 04/2006
3	Inclusion Body Myositis 10/2021 - 11/2012
2	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 09/2002
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2021 - 01/2019
2	Disease Progression 01/2019 - 01/2017
2	Pneumonia (Pneumonitis) 10/2018 - 08/2016
2	Arthritis (Polyarthritis) 01/2018 - 01/2016
2	Neoplasms (Cancer) 01/2017 - 08/2009
2	Dermatomyositis (Dermatopolymyositis) 01/2017 - 08/2009
2	Immune System Diseases (Immune Disorders) 01/2016 - 09/2005
1	Left Ventricular Dysfunction 01/2022
1	Osteitis 01/2020
1	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 01/2020
1	Rhinosinusitis 01/2020
1	Systemic Vasculitis 01/2019
1	Genetic Risk Score 01/2018
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2018
1	Vascular Remodeling 11/2017
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 11/2017
1	Giant Cell Arteritis (Horton Disease) 01/2017
1	Sclerosing Cholangitis 01/2017
1	Skin Diseases (Skin Disease) 01/2017
1	Takayasu Arteritis (Arteritis, Takayasu's) 01/2017
1	Spontaneous Abortion (Miscarriage) 01/2017
1	Liver Diseases (Liver Disease) 01/2017
1	Polymyositis 01/2017
1	Ulcerative Colitis 01/2017
1	Pleurisy (Pleuritis) 01/2016
1	Pericarditis 01/2016
1	Vascular System Injuries 08/2015
1	digital ulcers 08/2015
1	Disease Susceptibility (Diathesis) 04/2015

Drug/Important Bio-Agent (IBA)

10	AntibodiesIBA 01/2018 - 08/2009
9	AutoantibodiesIBA 01/2022 - 09/2002
7	Glutens (Glutelin)IBA 01/2019 - 09/2002
6	Peptides (Polypeptides)IBA 01/2017 - 09/2002
5	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2016
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 08/2003
3	AntigensIBA 01/2019 - 04/2006
3	Ligases (Synthetase)IBA 01/2017 - 08/2009
3	Protein Glutamine gamma Glutamyltransferase 2IBA 08/2003 - 09/2002
2	EndostatinsIBA 01/2022 - 08/2015
2	InterferonsIBA 01/2022 - 01/2021
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2021
2	beta-cyclodextrin tetradecasulfate (CTDS)IBA 01/2019 - 01/2016
2	Carbon MonoxideIBA 01/2019 - 05/2015
2	Amino Acids FDA Link 01/2017 - 04/2015
2	HLA-DRB1 Chains (HLA DRB1)IBA 01/2017 - 01/2017
2	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 04/2006 - 09/2002
1	C-Reactive ProteinIBA 01/2022
1	Complement C4 (Complement Component 4)IBA 01/2022
1	CytokinesIBA 01/2022
1	Angiopoietin-2IBA 01/2022
1	LigandsIBA 01/2022
1	OsteopontinIBA 01/2022
1	LipidsIBA 01/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022
1	Interleukin-13IBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2019
1	HLA-DQ Antigens (HLA-DQ)IBA 01/2019
1	Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA 01/2019
1	ChemokinesIBA 10/2018
1	Biocompatible Materials (Biomaterials)IBA 01/2018
1	arginine deiminaseIBA 01/2018
1	Protein-Arginine Deiminase Type 4IBA 01/2018
1	EpitopesIBA 01/2018
1	anti-scl-70 autoantibodiesIBA 01/2018
1	Vitamin D FDA LinkGeneric 01/2018
1	Platelet-Derived Growth FactorIBA 11/2017
1	Proto-Oncogene Proteins c-fos (FRAs)IBA 11/2017
1	Matrix Metalloproteinase 10 (Stromelysin 2)IBA 11/2017
1	PlasminogenIBA 01/2017
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2017
1	RNA Polymerase IIIIBA 01/2017
1	Tumor Necrosis Factor InhibitorsIBA 01/2017
1	Chemokine CCL18IBA 08/2016
1	U1 Small Nuclear RibonucleoproteinIBA 01/2016
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2015
1	Signal Recognition ParticleIBA 08/2015
1	Rituximab (Mabthera)FDA Link 08/2015
1	HLA-B Antigens (HLA-B)IBA 03/2015
1	Brain Natriuretic Peptide (Natrecor)FDA Link 07/2013
1	pro-brain natriuretic peptide (1-76)IBA 07/2013

Therapy/Procedure

4	Therapeutics 10/2021 - 09/2002
2	Gluten-Free Diet 10/2021 - 10/2004
2	Fecal Microbiota Transplantation 01/2020 - 01/2020
1	Transplantation 01/2021
1	Nasal Surgical Procedures 01/2020
1	Operative Surgical Procedures 01/2020
1	Induced Abortion (Induced Abortions) 01/2017
1	Immunotherapy 01/2016